Location History:
- Bettingen, CH (2014)
- Reinach, CH (2017)
Company Filing History:
Years Active: 2014-2017
Title: The Innovative Mind of Marcel Tigges
Introduction
Marcel Tigges, based in Reinach, Switzerland, is a notable inventor in the field of pharmaceuticals, focusing on the treatment of drug-resistant infections. With two patents to his name, Tigges has made significant contributions to medical science, particularly in combating antibiotic resistance.
Latest Patents
Tigges' latest innovations include two groundbreaking pharmaceutical compositions. The first patent addresses a "Composition for treatment of pathogens that are resistant to tetracyclines." This invention involves compounds and compositions that are effective in treating bacterial infections caused by both Gram-positive and Gram-negative pathogens, specifically targeting tetracycline-resistant strains. These compounds are designed to bind to TetR, blocking the activation of resistance genes and enhancing the efficacy of tetracycline-related medications such as minocycline, doxycycline, and tigecycline.
The second patent entails a "Composition for treatment of tuberculosis." This innovative formulation includes a specific compound that has shown utility in treating multidrug-resistant tuberculosis. The composition incorporates various substituents and is characterized by its potential effectiveness against challenging strains of this detrimental disease.
Career Highlights
Marcel Tigges is a key player at Bioversys AG, where he leverages his expertise in pharmaceutical development. His position at the company underscores his commitment to advancing medical therapies that address urgent health crises, particularly in the realm of antibiotic resistance.
Collaborations
In his professional journey, Tigges has collaborated with esteemed colleagues, including Marc Gitzinger and Peter Schneider. Together, they contribute to Bioversys AG's mission to innovate and enhance therapeutic solutions for infectious diseases.
Conclusion
Marcel Tigges exemplifies the spirit of innovation in the pharmaceutical industry, using his inventive prowess to tackle pressing health challenges such as antibiotic resistance and tuberculosis. His contributions through patents not only showcase his dedication to science but also promise a brighter future for medical treatments that combat resistant pathogens effectively.